Dr Reddys Laboratories (RDY) Cash & Current Investments (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Cash & Current Investments of $166.0 million for Q1 2026, down 7.26% year-over-year from $179.0 million in Q1 2025, and down 7.26% quarter-over-quarter from $179.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Cash & Current Investments (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Cash & Current Investments history runs 18 years deep, the most recent figure standing at $166.0 million for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 7.26% year-over-year to $166.0 million; the TTM figure through Mar 2026 stood at $166.0 million (down 7.26% YoY), while the FY2026 annual figure was $166.0 million, down 7.26% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $166.0 million, down from $179.0 million in the prior quarter.
- The five-year high for Cash & Current Investments was $776.0 million in Q1 2023, with the low at $87.0 million in Q1 2024.
- The 5-year median for Cash & Current Investments is $432.0 million (2022), against an average of $424.3 million.
- The sharpest annual moves came in 2022 and 2024: Cash & Current Investments surged 165.91% in 2022, then slumped 88.79% in 2024.
- Dr Reddys Laboratories' Cash & Current Investments stood at $432.0 million in 2022, then jumped by 72.45% to $745.0 million in 2023, then tumbled by 88.32% to $87.0 million in 2024, then jumped by 105.75% to $179.0 million in 2025, then declined by 7.26% to $166.0 million in 2026.
- Business Quant data shows RDY's Cash & Current Investments at $166.0 million in Q1 2026, $179.0 million in Q1 2025, and $87.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 164.00 Mn |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn | 656.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 166.00 Mn |
| Mar 31, 2025 | 179.00 Mn |
| Mar 31, 2024 | 87.00 Mn |
| Jun 30, 2023 | 745.00 Mn |
| Mar 31, 2023 | 776.00 Mn |
| Jun 30, 2022 | 432.00 Mn |
| Mar 31, 2022 | 585.00 Mn |
| Mar 31, 2021 | 220.00 Mn |
| Dec 31, 2020 | 291.00 Mn |
| Sep 30, 2020 | 357.00 Mn |
| Mar 31, 2020 | 341.00 Mn |
| Dec 31, 2019 | 280.00 Mn |
| Sep 30, 2019 | 427.00 Mn |
| Mar 31, 2019 | 37.00 Mn |
| Dec 31, 2018 | 359.00 Mn |
| Jun 30, 2018 | 249.00 Mn |
| Mar 31, 2018 | 346.00 Mn |
| Dec 31, 2017 | 344,000.00 Bn |
| Sep 30, 2017 | 263,000.00 Bn |
| Jun 17, 2017 | 226.00 |